Immunovant, Inc. IMVT United States — Net operating loss carry forwards

Other geography segments

Similar metrics at other companies

USBU.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards

$2.52B-9.1%

DOCNNet Operating Loss Carryforwards

$6.5M-63.4%

RALNet Operating Loss Carryforwards

$97.7M—

SNNet Operating Loss Carryforwards

$16.14M+61.2%

CWNet Operating Loss Carryforwards

$21.3M+15.1%

WMBU.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards

$325M-18.3%

Questions, answered.

What is Immunovant, Inc.'s united states — net operating loss carry forwards?

Immunovant, Inc. (IMVT) reported united states — net operating loss carry forwards of $195.2M in Q1 2026.

How has Immunovant, Inc.'s united states — net operating loss carry forwards changed year-over-year?

Immunovant, Inc.'s united states — net operating loss carry forwards increased by 300.8% year-over-year, from $48.7M to $195.2M.

What does united states — net operating loss carry forwards mean?

Represents the accumulated tax losses from prior periods that can be applied to offset future taxable income within the United States. These carryforwards serve as a valuable tax asset that can reduce future cash tax liabilities. Investors track this to estimate the potential for future tax savings as the company moves toward profitability.